Moreover, the prevalence of EGFR is highest among patients with NSCLC with an adenocarcinoma histology, while it occurs only rarely in NSCLC patients with squamous cell carcinoma histology and small cell lung cancer (SCLC) [39,40,41]. This evidence concerns the gene EGFR and adenocarcinoma.